Irreversible Inhibition Of Her2 Activating Mutations With Neratinib Enhances The Pre-Clinical Efficacy Of Trastuzumab Emtansine And Trastuzumab DeruxtecanRon Bose,Shunqiang Li,Tina M. Primeau,Maureen K. Highkin,Ashley R. Tipton,Nagalaxmi Vemalapally,Xuefeng Gao,Gail Sudlow,Irmina Diala,Yu Tao,Jingqin Luo,Ian Hagemann,Chieh-Yu Lin,Richard P. Bryce,Alshad S. Lalani,Samuel Achilefu,Cynthia X. MaCANCER RESEARCH(2021)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要